Business
Announcement on Obtaining the US FDA Drug Registration Approval for Nicardipine Hydrochloride Injection
Announcement on Obtaining the US FDA Drug Registration Approval for Nicardipine Hydrochloride Injection
About this update from Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A
Announcement on Obtaining the US FDA Drug Registration Approval for Nicardipine Hydrochloride InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment